01 1Centaur Pharmaceuticals
01 1OXAZEPAM USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-08-25
Pay. Date : 2014-04-25
DMF Number : 22060
Submission : 2008-09-30
Status : Active
Type : II
20
Centaur Pharmaceuticals Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is OXAZEPAM USP, with a corresponding US DMF Number 22060.
Remarkably, this DMF maintains an Active status since its submission on September 30, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 25, 2014, and payment made on April 25, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
